Government Funded Inventions

KEI efforts to address pricing and other public interest issues in more than 22 different NIH licensing cases, involving both patents and data rights, are here:

Our work on the Sanofi/Army Zika vaccine license is here.

Xtandi is an Army and NIH funded invention, patented by UCLA. Our work on the efforts to get the Army or the NIH to use their march-in or royalty free license rights to obtain lower prices are collected here:

The work on government funded CRISPR inventions is here:

The Fabrazyme patent disputes are here:

The 2004 and 2012 ritonavir cases are here:

Many of the other disputes and commentary on government funded inventions are listed below.